Of particular importance is triple-negative breast cancer (TNBC), classified as tumors that do not express the estrogen receptor (ER), the progesterone receptor (PR), or the human epidermal growth factor receptor 2 (HER2) [26,27]. Here, PGR is linked to triple-negative breast carcinoma.